Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2025 09:00 ET | Source: Xcellon Biologics

IntoCell and Xcellon Biologics Announce MOU to Expand Access to Next-Generation ADC Technologies

IntoCell and Xcellon Biologics partner to expand ADC development access, combining IntoCell's OHPAS payload-linker platform with Xcellon's CDMO expertise.
October 13, 2025 07:59 ET | Source: Research and Markets

Conjugated Drugs (XDCs) in Oncology Market Intelligence Tool Launched – Covering 2,500+ Pipeline Drugs and 1,300+ Funding Rounds

Dublin, Oct. 13, 2025 (GLOBE NEWSWIRE) -- The "Unlocking Opportunity: Dominate the Market of Conjugated Drugs (XDCs) in Oncology with Confidence" directory has been added to ...
September 03, 2025 16:07 ET | Source: Radiance BioPharma

Radiance Biopharma Signs Exclusive License For ‘First In Class’ c-Met/EGFR Targeted Nano Antibody ADC

BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or "Company"), a clinical-stage biotechnology company, announced that it has signed an Exclusive License Agreement...
August 26, 2025 04:11 ET | Source: Research and Markets

Bispecific Antibody Drug Conjugates Clinical Trials and Competitive Landscape Report 2025 | Over 100 Bispecific ADCs Progressing in Clinical Trials

Dublin, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The "Bispecific Antibody Drug Conjugates Clinical Trials, Development Platforms, Competitive Landscape & Market Opportunity Insight 2025" report has...
August 15, 2025 08:24 ET | Source: Research and Markets

Antibody Drug Conjugates Market Analysis Report 2025 | ADCs Set for Growth Amid Regulatory Evolutions and Technological Advances

Dublin, Aug. 15, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugates: Market Share, and Growth Analysis by Product Type (Monoclonal Antibodies, Small Molecule Drugs), Application, End User,...
August 13, 2025 07:48 ET | Source: Research and Markets

Antibody Drug Conjugate (ADC) Market Report 2025: Industry Set to Double by 2030 Driven by Next-Gen Oncology Innovations, Reaching $16 Billion

Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market by Payload Type (Auristatins, Calicheamicins, Maytansinoids), Indication (Breast Cancer, Hematological Cancer, Lung...
August 06, 2025 04:22 ET | Source: Research and Markets

Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines

Dublin, Aug. 06, 2025 (GLOBE NEWSWIRE) -- The "Cancer Antibody Drug Conjugates Market Opportunity, Patent, Price, Approved Drug Sales & Clinical Trials Insight 2031" report has been added to ...
July 03, 2025 04:39 ET | Source: Research and Markets

State of the Biopharmaceutical Industry, Mid Year 2025 Report - Vanzacaftor Calcium + Deutivacaftor + Tezacaftor for Cystic Fibrosis is Expected to Have the Highest Commercial Success

Dublin, July 03, 2025 (GLOBE NEWSWIRE) -- The "The State of the Biopharmaceutical Industry 2025 (Mid-Year) Edition" report has been added to ResearchAndMarkets.com's offering. The report...
May 20, 2025 04:16 ET | Source: Research and Markets

Global Antibody Drug Conjugates Market Report 2025-2035: North America Leads ADC Market Growth with Strong Infrastructure and Innovations

Dublin, May 20, 2025 (GLOBE NEWSWIRE) -- The "Global Antibody Drug Conjugates Market - 2025-2035: Focus on Product, Application, Target, Payload Type, Linker Type, Linker Technology, and Geography"...
May 19, 2025 11:27 ET | Source: Research and Markets

Europe Contract Research Organization Market Size and Forecast Report 2025-2031: Stiff Competition and Pricing Pressures Hampering Growth

Dublin, May 19, 2025 (GLOBE NEWSWIRE) -- The "Europe Contract Research Organization Market Size and Forecast, Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service Type,...